Key facts
- This page summarizes Christopher Brett Primiano's Form 4 filing for Aura Biosciences, Inc. (AURA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 29 Oct 2021, 19:23.
Christopher Brett Primiano - 28 Oct 2021 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)
- Reporting relationship
- Chief Business Officer
- Issuer ticker
- AURA
- Reported as of
- 28 Oct 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Julie Feder
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Christopher Brett Primiano filed Form 4 for Aura Biosciences, Inc. (AURA) on 29 Oct 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AURA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +8,750
- Change %
- Price
- $0.000000
- Shares after
- 8,750
- Date
- 28 Oct 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AURA
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +37,500
- Change %
- Price
- Shares after
- 37,500
- Date
- 28 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 37,500
- Exercise price
- $14.00
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These shares were acquired pursuant to a restricted stock unit award under the Company's 2021 Stock Option and Incentive Plan. Each restricted stock unit represents the right to receive one share of the Company's common stock. These restricted stock units vest in four substantially equal annual installments beginning on the one year anniversary of the date of grant.
Footnote F2
The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of October 28, 2022 with the remainder vesting thereafter in annual installments.